Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Landway Bionanometer Technology Joint-Stock Co., Ltd. is a Chinese biotechnology company specializing in the development and production of nanometer-scale biological materials. Based in Xi'an, the company utilizes its proprietary Bionanometer Technology platform to manufacture high-purity biological powders for use in health foods, cosmetics, and traditional Chinese medicine. Its commercial product portfolio includes nano-calcium, nano-pearl powder, and nano-selenium, as well as biological disinfection products. Historically, the company operated as a subsidiary of China Bionanometer Industries Corporation (later US-China Biomedical Technology Inc.), which was publicly traded in the United States. However, the parent company's securities registration was revoked by the SEC in 2021 following a period of filing delinquency, and the company is currently considered inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Landway Bionanometer Technology.